Edwin Zhang
Stock Analyst at HC Wainwright & Co.
(n/a)
# 4,371
Out of 4,732 analysts
5
Total ratings
n/a
Success rate
-67.02%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Edwin Zhang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RARE Ultragenyx Pharmaceutical | Initiates: Buy | $106 | $40.00 | +165.00% | 1 | Sep 30, 2021 | |
| LOGC ContextLogic | Initiates: Buy | $15 | $6.87 | +118.34% | 1 | Jun 7, 2021 | |
| FGEN FibroGen | Downgrades: Neutral | n/a | $0.57 | - | 2 | Apr 7, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | $26 | $4.84 | +437.19% | 1 | Feb 8, 2021 |
Ultragenyx Pharmaceutical
Sep 30, 2021
Initiates: Buy
Price Target: $106
Current: $40.00
Upside: +165.00%
ContextLogic
Jun 7, 2021
Initiates: Buy
Price Target: $15
Current: $6.87
Upside: +118.34%
FibroGen
Apr 7, 2021
Downgrades: Neutral
Price Target: n/a
Current: $0.57
Upside: -
Aldeyra Therapeutics
Feb 8, 2021
Initiates: Buy
Price Target: $26
Current: $4.84
Upside: +437.19%